Non Surgical Bio Implants Global Market Research Sources, End user Analysis and Forecast to 2022
ReportsWeb.com published “Non Surgical Bio Implants Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, September 12, 2017 ) Rising aged population, technological advancement in bio-implants, high level of healthcare awareness and rising disposable incomes are the factors driving the non-surgical bio-implants market. However, high treatment cost, increasing application areas mostly medical and aesthetic for biomaterials used in non-surgical bio-implants and reimbursement issues are the factors hindering the market.
Collagen based bio-implants holds major share owing to its lower cost and easy availability. North America region has the major market for non-surgical bio-implants in terms of revenue owing to huge number of key players and strong healthcare infrastructure. Europe region is the second leading non-surgical bio-implants market due to technical advancements in the region.
For more information @ http://www.reportsweb.com/non-surgical-bio-implants-global-market-outlook-2015-2022
Some of the key players in the market include Novatex Bioengineering SA, LCA Pharmaceuticals, Moma Therapeutics, Inc., Johnson & Johnson, Kythera Pharmaceuticals, Inc., Anika Therapeutics, Inc., Fidia Farmaceutici, FibroGen, Inc., Hangzhou Gallop Biological Products Co. Ltd., Albiorex International BioPolymer GmbH & Co. KG, Adoderm, Nordic Aesthetics, Teoxane Laboratoires and Coapt Systems.
Bio-implants Type Covered:
- Injectable biomaterials
- Hyaluronan
- Hydrogels
- Hyaluronic acid
- Collagen
- Calcium phosphate ceramic pastes
- Biopolymers
- Hydroxyapatite
- Alloplastic biomaterials
- Acrylic hydrogel
- Non-surgical bio-implants
- Viscoaugmentation bio-implants
- Viscosupplementation bio-implants
.
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001216341/sample
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
8 Company Profiling
8.1 Novatex Bioengineering SA
8.2 LCA Pharmaceuticals
8.3 Moma Therapeutics, Inc.
8.4 Johnson & Johnson
8.5 Kythera Pharmaceuticals, Inc.
8.6 Anika Therapeutics, Inc.
8.7 Fidia Farmaceutici
8.8 FibroGen, Inc.
8.9 Hangzhou Gallop Biological Products Co. Ltd.
8.10 Albiorex International
8.11 BioPolymer GmbH & Co. KG
8.12 Adoderm
8.13 Nordic Aesthetics
8.14 Teoxane Laboratoires
8.15 Coapt Systems
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216341/buying
Collagen based bio-implants holds major share owing to its lower cost and easy availability. North America region has the major market for non-surgical bio-implants in terms of revenue owing to huge number of key players and strong healthcare infrastructure. Europe region is the second leading non-surgical bio-implants market due to technical advancements in the region.
For more information @ http://www.reportsweb.com/non-surgical-bio-implants-global-market-outlook-2015-2022
Some of the key players in the market include Novatex Bioengineering SA, LCA Pharmaceuticals, Moma Therapeutics, Inc., Johnson & Johnson, Kythera Pharmaceuticals, Inc., Anika Therapeutics, Inc., Fidia Farmaceutici, FibroGen, Inc., Hangzhou Gallop Biological Products Co. Ltd., Albiorex International BioPolymer GmbH & Co. KG, Adoderm, Nordic Aesthetics, Teoxane Laboratoires and Coapt Systems.
Bio-implants Type Covered:
- Injectable biomaterials
- Hyaluronan
- Hydrogels
- Hyaluronic acid
- Collagen
- Calcium phosphate ceramic pastes
- Biopolymers
- Hydroxyapatite
- Alloplastic biomaterials
- Acrylic hydrogel
- Non-surgical bio-implants
- Viscoaugmentation bio-implants
- Viscosupplementation bio-implants
.
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001216341/sample
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
8 Company Profiling
8.1 Novatex Bioengineering SA
8.2 LCA Pharmaceuticals
8.3 Moma Therapeutics, Inc.
8.4 Johnson & Johnson
8.5 Kythera Pharmaceuticals, Inc.
8.6 Anika Therapeutics, Inc.
8.7 Fidia Farmaceutici
8.8 FibroGen, Inc.
8.9 Hangzhou Gallop Biological Products Co. Ltd.
8.10 Albiorex International
8.11 BioPolymer GmbH & Co. KG
8.12 Adoderm
8.13 Nordic Aesthetics
8.14 Teoxane Laboratoires
8.15 Coapt Systems
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216341/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results